menu
    • menu

    Company profile for Mabxience

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceutical medicines. We incorporate the latest state-of-the-art technology in our development and manufacturing platform, across 3 multi product API facility and our filling site. We are committed to global quality standards to manufacture & supply...
    mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceutical medicines. We incorporate the latest state-of-the-art technology in our development and manufacturing platform, across 3 multi product API facility and our filling site. We are committed to global quality standards to manufacture & supply our products worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MabxienceSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Manuel Pombo Angulo 28 3rd floor, Madrid Postal code: 28050
    Telephone
    Telephone
    +34 917 711 500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mabxience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mabxience/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Mabxience

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    mAbxience's Denosumab Biosimilars Approved by European Commission
    mAbxience's Denosumab Biosimilars Approved by European Commission

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mabxience-announces-european-commission-approval-of-denosumab-biosimilars-302496762.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share
    mAbxience, Corapharm Partner for Southeast Europe Deal
    mAbxience, Corapharm Partner for Southeast Europe Deal

    02 Jun 2025

    // PRESS RELEASE

    https://mabxience.com/mabxience-and-corapharm-announce-strategic-licensing-agreement-for-biosimilar-candidate-in-southeast-europe/

    PRESS RELEASE
    02 Jun 2025
    Share Share
    mAbxience & Abiogen Pharma Sign Italy Biosimilar Deal
    mAbxience & Abiogen Pharma Sign Italy Biosimilar Deal

    26 May 2025

    // PRESS RELEASE

    https://mabxience.com/mabxience-and-abiogen-pharma-announce-strategic-licensing-agreement-for-biosimilar-candidate-in-italy/

    PRESS RELEASE
    26 May 2025
    Share Share
    mAbxience, Egis Ink Deal For Biosimilars In Central Europe
    mAbxience, Egis Ink Deal For Biosimilars In Central Europe

    12 Nov 2024

    // PRESS RELEASE

    https://mabxience.com/mabxience-and-egis-enter-strategic-license-agreement-for-biosimilar-candidates-in-key-central-and-eastern-european-markets/

    PRESS RELEASE
    12 Nov 2024
    Share Share
    Teva, mAbxience Add New Oncology Biosimilar To Partnership
    Teva, mAbxience Add New Oncology Biosimilar To Partnership

    03 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/03/2957702/0/en/Teva-and-mAbxience-Expand-Strategic-Partnership-to-include-an-additional-Oncology-Biosimilar-Candidate.html

    GLOBENEWSWIRE
    03 Oct 2024
    Share Share
    MAbxience Names New Chief Executive Officer
    MAbxience Names New Chief Executive Officer

    10 May 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-05-10/mabxience-names-new-chief-executive-officer/?widget=listSection

    CONTRACT PHARMA
    10 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search